3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
6
Depression
6
Breast Neoplasms
6
Multiple Myeloma
5
Leukemia
4
Brain Neoplasms
4
Waldenstrom Macroglobulinemia
3
Sezary Syndrome
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Vomiting
2
Nausea
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Interventions
telapristone acetate
13
estradiol, norethindrone drug combination
9
elagolix
7
Estradiol
7
relugolix
6
Norethindrone Acetate
5
vilaprisan
4
ulipristal acetate
4
Sugars
3
Uterine Myomectomy
2
Lidocaine
2
Leuprolide
2
Letrozole
2
ulipristal
1
epigallocatechin gallate
1
Vitamin B 6
1
Uterine Artery Embolization
1
Tranexamic Acid
1
Therapeutics
1
Standard of Care
1
Sodium Chloride
1
Ropivacaine
1
Rocuronium
1
Progesterone
1
Pregabalin
1
Morphine
1
Misoprostol
1
Mifepristone
1
Injections, Subcutaneous
1
Ibuprofen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Leiomyoma
×
Therapeutics
×
Clear all
NCT04272216
2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
99 enrolled
15 charts